Press release
Acute Myeloid Leukemia Pipeline Analysis (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals, Competitive Landscape | Abbvie, Synimmune, Agastiya, Astellas, NexImmune, BerGenBio, Celgene, CellCentric, Chimerix, Pfizer
"Acute Myeloid Leukemia Pipeline Insight, 2023" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Acute Myeloid Leukemia Therapeutics Market.
The report provides a detailed description of the Acute Myeloid Leukemia drugs, including the mechanism of action, type, stage, route of administration, molecule type, clinical studies, inactive pipeline products, and NDA approvals (if any). The report also covers commercial and clinical activities of the pipeline products from the pre-clinical developmental phase to the marketed stage. Additionally, it presents the ongoing developments in the therapeutics segment, including collaborations, licensing, mergers & acquisitions (M&A), funding, designations, and other product-related details.
Get a Detailed Overview of the Acute Myeloid Leukemia Clinical Trial Activities and Regulatory Developments in the domain @
https://www.delveinsight.com/report-store/acute-myeloid-leukemia-aml-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Acute Myeloid Leukemia Pipeline Analysis
The report provides insights into:
• The report provides detailed insights into the key companies that are developing Acute Myeloid Leukemia therapies.
• The report also evaluates different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Acute Myeloid Leukemia treatment.
• It analyzes the key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• It navigates the emerging Acute Myeloid Leukemia drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement, and financing details for future advancement in the Acute Myeloid Leukemia treatment market.
Learn More about the Clinical and Commercial Development Activities in the Acute Myeloid Leukemia Therapeutics Domain @
https://www.delveinsight.com/report-store/acute-myeloid-leukemia-aml-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Acute Myeloid Leukemia Therapeutics Analysis
There are approx. 260+ key companies developing Acute Myeloid Leukaemia therapies. Currently, Gamida Cell is leading the therapeutics market with its Acute Myeloid Leukaemia drug candidates in the most advanced stage of clinical development.
Acute Myeloid Leukemia Companies in the Therapeutics Market Include:
Abbvie, Actinium Pharmaceuticals, Agastiya Biotech, AGC Biologics S.p.A., Agios Pharmaceuticals, Allogene therapeutics, Aprea Therapeutics, Aptevo Therapeutics, Armaceutica, Arog Pharmaceuticals, Astellas Pharma, Astex Pharmaceuticals, Inc., AstraZeneca, Bellicum Pharmaceuticals, BerGenBio ASA, Bio-Path Holdings, Biosight Ltd., Bristol-Myers Squibb, Cardiff Oncology, Celgene, CellCentric Ltd., Chimerix, Clear Creek Bio Inc., CSPC ZhongQi Pharmaceutical Technology Co., Ltd., Curis, Inc., Daiichi Sankyo., DCPrime BV, Delta-Fly Pharma, Forma Therapeutics, GEMoaB Monoclonals, Gilead Sciences, GlycoMimetics, GlycoMimetics Incorporated, GT Biopharma, Inc., Hanmi Pharmaceutical Company Limited, Immune-Onc Therapeutics, Immunicum, ImmunityBio, ImmunoGen, Inc., Immunomedics, Inc., Incyte Corporation, Janssen Research & Development, LLC, Jasper Therapeutics, Jazz Pharmaceuticals, Kronos Bio, MacroGenics, MediGene, Molecular Partners, New Epsilon Innovation Limited, NexImmune Inc., Novartis, Oncoceutics, Orca Bio, PersonGen BioTherapeutics, Pfizer, Poseida Therapeutics, Precigen, Inc., Rafael Pharmaceuticals Inc., Sellas Life Sciences Group, Sumitomo Dainippon Pharma Co., Ltd., Syndax Pharmaceuticals, Synimmune GmbH, Syros Pharmaceuticals, Takeda Oncology, TC BioPharm, Teva Pharmaceutical Industries, Xencor, Inc., and others.
Emerging and Marketed Acute Myeloid Leukemia Therapies Covered in the Report Include:
• Omidubicel: Gamida Cell
• Uproleselan: GlycoMimetics
• ALT 803: ImmunityBio
• BPX-501: Bellicum Pharmaceuticals
• Devimistat (CPI-613): Rafael Pharmaceuticals Inc.
• Crenolanib: Arog Pharmaceuticals
And Many More
Get an in-depth Assessment of the Emerging Therapies and Acute Myeloid Leukemia Companies Actively Working in the Market @
https://www.delveinsight.com/sample-request/acute-myeloid-leukemia-aml-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
The Report Covers the Emerging Acute Myeloid Leukemia Therapies Under Different Phases of Clinical Development Like -
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued and inactive candidates
Route of Administration
The Acute Myeloid Leukaemia pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
• Oral
• Intravenous
• Subcutaneous
Molecule Type
Acute Myeloid Leukaemia Products have been categorized under various Molecule types such as
• Small molecule
• Cell Therapy
• Peptides
• Polymer
• Small molecule
• Gene therapy
Request for Sample PDF to Understand More About the Acute Myeloid Leukemia Treatment Outlook and Future Perspectives @
https://www.delveinsight.com/sample-request/acute-myeloid-leukemia-aml-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Table of Content
1. Report Introduction
2. Executive Summary
3. Acute Myeloid Leukemia Current Treatment Patterns
4. Acute Myeloid Leukemia - DelveInsight's Analytical Perspective
5. Therapeutic Assessment
6. Acute Myeloid Leukemia Late-Stage Products (Phase-III)
7. Acute Myeloid Leukemia Mid-Stage Products (Phase-II)
8. Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Acute Myeloid Leukemia Discontinued Products
13. Acute Myeloid Leukemia Product Profiles
14. Acute Myeloid Leukemia Companies
15. Acute Myeloid Leukemia Drugs
16. Dormant and Discontinued Products
17. Acute Myeloid Leukemia Unmet Needs
18. Acute Myeloid Leukemia Future Perspectives
19. Acute Myeloid Leukemia Analyst Review
20. Appendix
21. Report Methodology
Get Detailed Insights About the Reports Offerings @
https://www.delveinsight.com/sample-request/acute-myeloid-leukemia-aml-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
------------------------------------------------------------------------------------------------------------------------------
Discover DelveInsight's Comprehensive Market Research and Consulting Services:
https://www.delveinsight.com/market-research
Elevate your industry insights with our comprehensive medical devices market assessment reports. Visit to gain a strategic edge through expert analysis and in-depth coverage of the latest trends, innovations, and market dynamics, at:
https://www.delveinsight.com/medical-devices
Empowering Cancer Care: DelveInsight's oncology consulting services offer personalized guidance and cutting-edge expertise to navigate the ongoing clinical, commercial, and regulatory developments, visit for more details:
https://www.delveinsight.com/oncology
Other Trending Healthcare Reports by DelveInsight
Schizophrenia Market
https://www.delveinsight.com/report-store/schizophrenia-market
Human Immunodeficiency Virus Type-1 (HIV-1) Market
https://www.delveinsight.com/report-store/human-immunodeficiency-virus-type-1-hiv-1-market
US Healthcare Outlook Bulimia Nervosa Market
https://www.delveinsight.com/report-store/bulimia-nervosa-market
Hepatitis B Virus (HBV) Infection Market
https://www.delveinsight.com/report-store/hepatitis-b-virus-hbv-infection-market
Pancreatic Cancer Market
https://www.delveinsight.com/report-store/pancreatic-cancer-market
Hepatitis C Market
https://www.delveinsight.com/report-store/hepatitis-c-market
Obsessive-Compulsive Disorder Market
https://www.delveinsight.com/report-store/obsessive-compulsive-disorder-market
Cytomegalovirus (CMV) Infections Market
https://www.delveinsight.com/report-store/cytomegalovirus-cmv-infection-market-insight-epidemiology-and-market-forecast
Spinal Fusion Devices Market
https://www.delveinsight.com/report-store/spinal-fusion-devices-market
Gastro Intestinal Bleeding Market
https://www.delveinsight.com/report-store/gastro-intestinal-bleeding-market
Giant-Cell Arteritis Market
https://www.delveinsight.com/report-store/giant-cell-arteritis-market
Traveler's Diarrhea Market
https://www.delveinsight.com/report-store/travelers-diarrhea-market
Hemophilia A Market
https://www.delveinsight.com/report-store/hemophilia-a2030-market
Patent Foramen Ovale (PFO) Closure Devices Market
https://www.delveinsight.com/report-store/patent-foramen-ovale-closure-devices-market
Invasive Pneumococcal Disease Market
https://www.delveinsight.com/report-store/invasive-pneumococcal-disease-market
Echocardiography Devices Market
https://www.delveinsight.com/report-store/echocardiography-devices-market
Primary Immune Deficiency (PID) Market
https://www.delveinsight.com/report-store/primary-immune-deficiency-pid-market
Narcolepsy Market
https://www.delveinsight.com/report-store/narcolepsy-market
Periodontal Disease Market
https://www.delveinsight.com/report-store/periodontal-disease-market
Postoperative Nausea and Vomiting (PONV) Market
https://www.delveinsight.com/report-store/postoperative-nausea-and-vomiting-ponv-market
Helicobacter Pylori Infections Market
https://www.delveinsight.com/report-store/helicobacter-pylori-infections-market
Acute Lymphoblastic Leukemia (ALL) Market
https://www.delveinsight.com/report-store/acute-lymphoblastic-leukemia-all-market
Hemodynamic Monitoring Systems Market
https://www.delveinsight.com/report-store/hemodynamic-monitoring-system-market
Peripheral Neuritis Market
https://www.delveinsight.com/report-store/peripheral-neuritis-market
Food Allergy Market
https://www.delveinsight.com/report-store/food-allergy-market-insights
Embolotherapy Market
https://www.delveinsight.com/report-store/embolotherapy-market
Psychosis Market
https://www.delveinsight.com/report-store/psychosis-market
Inguinal Hernia Market
https://www.delveinsight.com/report-store/inguinal-hernia-market
Asthma Market
https://www.delveinsight.com/report-store/asthma-market
Spinal Non-Fusion Devices Market
https://www.delveinsight.com/report-store/spinal-non-fusion-devices-market
Corneal Dystrophy Market
https://www.delveinsight.com/report-store/corneal-dystrophy-market
Myasthenia Gravis Market
https://www.delveinsight.com/report-store/myasthenia-gravis-market
Substance use disorder Market
https://www.delveinsight.com/report-store/substance-use-disorder-market
Atopic Dermatitis Market
https://www.delveinsight.com/report-store/atopic-dermatitis-market
Injectable Drug Delivery Devices Market
https://www.delveinsight.com/report-store/injectable-drug-delivery-devices-market
Atherectomy Devices Market
https://www.delveinsight.com/report-store/atherectomy-devices-market
Chemotherapy Induced Nausea and Vomiting Market
https://www.delveinsight.com/report-store/chemotherapy-induced-nausea-and-vomiting-market
Structural Heart Devices Market
https://www.delveinsight.com/report-store/structural-heart-devices-market-market
Diabetic Eye Disease Market
https://www.delveinsight.com/report-store/diabetic-eye-disease-market
Tissue Heart Valves Market
https://www.delveinsight.com/report-store/tissue-heart-valves-cardiovascular-prosthetic-devices-market
Cardiovascular Prosthetic Devices Market
https://www.delveinsight.com/report-store/tissue-heart-valves-cardiovascular-prosthetic-devices-market
Diabetic Macular Edema (DME) Market
https://www.delveinsight.com/report-store/diabetic-macular-edema-dme-market
End-Stage Renal Disease (ESRD) Market
https://www.delveinsight.com/report-store/end-stage-renal-disease-esrd-market
Gastroesophageal Reflux Disease (GERD) Market
https://www.delveinsight.com/report-store/gastroesophageal-reflux-disease-gerd-market
Renal Insufficiency Market
https://www.delveinsight.com/report-store/renal-insufficiency-market
Diabetic Retinopathy Market
https://www.delveinsight.com/report-store/diabetic-retinopathy-market
Artificial Cornea and Corneal Implant Market
https://www.delveinsight.com/report-store/artificial-cornea-and-corneal-implant-market
Herpes Simplex Market
https://www.delveinsight.com/report-store/herpes-simplex-market
Cardiac Monitoring System Market
https://www.delveinsight.com/report-store/cardiac-monitoring-system-market
Contact Info:
Shruti Thakur
Manager - Marketing & International Branding
Email: info@delveinsight.com
428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Acute Myeloid Leukemia Pipeline Analysis (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals, Competitive Landscape | Abbvie, Synimmune, Agastiya, Astellas, NexImmune, BerGenBio, Celgene, CellCentric, Chimerix, Pfizer here
News-ID: 3311240 • Views: …
More Releases from DelveInsight Business Research LLP
Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight and stay ahead…
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore…
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight…
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market…
More Releases for Acute
Acute Lymphoblastic Leukemia Therapeutics Market Size, Acute Lymphoblastic Leuke …
Acute Lymphoblastic Leukemia Therapeutics Market Dynamics are clarified by an in-depth review of facts on current and emerging trends. To understand a resource, the paper uses Porter's five forces to examine the importance of numerous qualities such as understanding of suppliers and customers, dangers provided by various agents, competitive strength, and promising new businesses. precious. Furthermore, the study covers numerous firms' Acute Lymphoblastic Leukemia Therapeutics research data, benefit, gross margin,…
Acute Conjunctivitis Treatment Market: The Future Insights Of Global Acute Conju …
Acute Conjunctivitis Treatment Market
Acute Conjunctivitis Treatment Market, or pink eye, is an irritation or inflammation of the conjunctiva that covers the white part of the eyeball. It can be caused by allergies or a bacterial or viral infection. Acute Conjunctivitis Treatment Market can be highly communicable and can be spread easily by the contact with secretions of eye from the infected person. Conjunctivitis often resolves on its own, but…
Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H …
ReportsWorldwide has announced the addition of a new report title Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H1, 2017 to its growing collection of premium market research reports.
GlobalData's clinical trial report, “Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H1, 2017" provides an overview of Acute Renal Failure (ARF) (Acute Kidney Injury) clinical trials scenario. This report provides top line data relating to…
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical T …
ReportsWorldwide has announced the addition of a new report title Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical Trials Review, H1, 2017 to its growing collection of premium market research reports.
GlobalData's clinical trial report, “Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical Trials Review, H1, 2017" provides an overview of Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) clinical trials scenario. This report provides top line data relating to…
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Tri …
ReportsWorldwide has announced the addition of a new report title Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Trials Review, H1, 2017 to its growing collection of premium market research reports.
GlobalData's clinical trial report, “Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Trials Review, H1, 2017" provides an overview of Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) clinical trials scenario. This report provides top line data relating to…
H2 2016 Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Therapeut …
Albany, New York, January 03, 2017: A recent forecast report focusing on the Acute Myelocytic Leukemia Market has been added to the wide portfolio of Market Research Hub (MRH). It is entitled as, “Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2016” which has been equipped by in-depth market examination with inputs from the industry experts. It covers the current market scenario and also its future growth…
